<?xml version="1.0" encoding="UTF-8"?>
<p>There was a significant (
 <italic>p</italic> ≤ 0.001) augmented serum expressions of inflammatory markers including TNF-
 <italic>α</italic>, IL-1
 <italic>β</italic>, IL-6, caspase-3, NO, and PGE-2 in diabetic-untreated animals as compared with the nondiabetic group. 
 <italic>L. regularis</italic> treatment in 150 mg/kg dose significantly decreased the serum expressions of TNF-
 <italic>α</italic> (
 <italic>p</italic> ≤ 0.01), IL-1
 <italic>β</italic> (
 <italic>p</italic> ≤ 0.01), IL-6 (
 <italic>p</italic> ≤ 0.05), and NO (
 <italic>p</italic> ≤ 0.05) as compared with the STZ group. The higher 
 <italic>L. regularis</italic> dose (300 mg/kg) significantly reduced the serum expressions of TNF-
 <italic>α</italic> (
 <italic>p</italic> ≤ 0.001), IL-1
 <italic>β</italic> (
 <italic>p</italic> ≤ 0.001), IL-6 (
 <italic>p</italic> ≤ 0.01), caspase-3 (
 <italic>p</italic> ≤ 0.01), NO (
 <italic>p</italic> ≤ 0.01), and PGE-2 (
 <italic>p</italic> ≤ 0.05) in diabetic rats as compared with the STZ group (
 <xref ref-type="fig" rid="fig2">Figure 2</xref>).
</p>
